Geneos Wealth Management’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $446K | Sell |
3,771
-19,288
| -84% | -$2.39M | 0.01% | 732 |
|
|
2025
Q4 | $2.9M | Buy |
23,059
+1,476
| +7% | +$193K | 0.07% | 294 |
|
|
2025
Q3 | $3.16M | Sell |
21,583
-3,377
| -14% | -$510K | 0.08% | 273 |
|
|
2025
Q2 | $3.89M | Sell |
24,960
-24,607
| -50% | -$3.9M | 0.1% | 262 |
|
|
2025
Q1 | $8.16M | Buy |
49,567
+34,862
| +237% | +$5.8M | 0.12% | 210 |
|
|
2024
Q4 | $2.4M | Buy |
14,705
+1,776
| +14% | +$318K | 0.08% | 264 |
|
|
2024
Q3 | $2.53M | Buy |
12,929
+4,866
| +60% | +$897K | 0.1% | 245 |
|
|
2024
Q2 | $1.4M | Buy |
8,063
+2,816
| +54% | +$469K | 0.06% | 308 |
|
|
2024
Q1 | $888K | Buy |
5,247
+699
| +15% | +$131K | 0.04% | 369 |
|
|
2023
Q4 | $898K | Buy |
4,548
+1,639
| +56% | +$290K | 0.04% | 345 |
|
|
2023
Q3 | $506K | Buy |
2,909
+389
| +15% | +$70.6K | 0.03% | 463 |
|
|
2023
Q2 | $434K | Sell |
2,520
-742
| -23% | -$128K | 0.02% | 486 |
|
|
2023
Q1 | $543K | Sell |
3,262
-1,350
| -29% | -$221K | 0.03% | 426 |
|
|
2022
Q4 | $676K | Buy |
4,612
+456
| +11% | +$67.5K | 0.04% | 357 |
|
|
2022
Q3 | $616K | Buy |
4,156
+435
| +12% | +$72.7K | 0.04% | 349 |
|
|
2022
Q2 | $648K | Buy |
3,721
+75
| +2% | +$13K | 0.03% | 429 |
|
|
2022
Q1 | $687K | Buy |
3,646
+438
| +14% | +$86.6K | 0.03% | 458 |
|
|
2021
Q4 | $782K | Sell |
3,208
-48
| -1% | -$10.5K | 0.03% | 465 |
|
|
2021
Q3 | $638K | Buy |
3,256
+75
| +2% | +$15.1K | 0.02% | 508 |
|
|
2021
Q2 | $612K | Sell |
3,181
-3,282
| -51% | -$570K | 0.02% | 511 |
|
|
2021
Q1 | $1.12M | Sell |
6,463
-18
| -0.3% | -$2.85K | 0.03% | 392 |
|
|
2020
Q4 | $518K | Buy |
6,481
+3,940
| +155% | +$641K | 0.02% | 527 |
|
|
2020
Q3 | $408K | Buy |
2,541
+558
| +28% | +$85.7K | 0.02% | 484 |
|
|
2020
Q2 | $263K | Buy |
1,983
+568
| +40% | +$74.2K | 0.01% | 581 |
|
|
2020
Q1 | $158K | Buy |
1,415
+327
| +30% | +$43.1K | 0.01% | 695 |
|
|
2019
Q4 | $144K | Buy |
1,088
+618
| +131% | +$76.8K | 0.01% | 812 |
|
|
2019
Q3 | $58K | Buy |
470
+13
| +3% | +$1.57K | ﹤0.01% | 1115 |
|
|
2019
Q2 | $51K | Buy |
457
+30
| +7% | +$3.14K | ﹤0.01% | 1176 |
|
|
2019
Q1 | $42K | Sell |
427
-237
| -36% | -$21.5K | ﹤0.01% | 1232 |
|
|
2018
Q4 | $56K | Buy |
664
+335
| +102% | +$30.2K | ﹤0.01% | 1042 |
|
|
2018
Q3 | $30K | Buy |
329
+29
| +10% | +$2.57K | ﹤0.01% | 1415 |
|
|
2018
Q2 | $25K | Sell |
300
-147
| -33% | -$12.4K | ﹤0.01% | 1362 |
|
|
2018
Q1 | $37K | Buy |
447
+150
| +51% | +$11.8K | ﹤0.01% | 1143 |
|
|
2017
Q4 | $21K | Hold |
297
| – | – | ﹤0.01% | 1366 |
|
|
2017
Q3 | $18K | Buy |
297
+147
| +98% | +$9.21K | ﹤0.01% | 1377 |
|
|
2017
Q2 | $9K | Hold |
150
| – | – | ﹤0.01% | 1584 |
|
|
2017
Q1 | $8K | Sell |
150
-28
| -16% | -$1.51K | ﹤0.01% | 1581 |
|
|
2016
Q4 | $9K | Hold |
178
| – | – | ﹤0.01% | 1483 |
|
|
2016
Q3 | $9K | Buy |
178
+28
| +19% | +$1.42K | ﹤0.01% | 1417 |
|
|
2016
Q2 | $7K | Sell |
150
-146
| -49% | -$6.9K | ﹤0.01% | 1443 |
|
|
2016
Q1 | $13K | Buy |
+296
| New | +$12.6K | ﹤0.01% | 1236 |
|
Other funds holding ZTS
VCM
VPM
Geneos Wealth Management's ZTS Position: Q1 2026 in Review
Geneos Wealth Management reduced its Zoetis (ZTS) stake by 84% in Q1 2026, selling an estimated $2.39M and leaving 3,771 shares worth $446K. The position accounts for 0.01% of the portfolio, ranked #732.
Geneos Wealth Management first reported a position in ZTS in Q1 2016 and has held it in 41 quarters since. The position peaked at $8.16M in Q1 2025. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.
- Geneos Wealth Management held 3,771 shares of Zoetis worth $446K as of Q1 2026.
- Geneos Wealth Management sold 19,288 Zoetis shares in Q1 2026, an estimated $2.39M.
- Zoetis made up 0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #732 holding.
- Geneos Wealth Management first reported a position in Zoetis in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Zoetis position peaked at $8.16M in Q1 2025.
- 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.